Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-30T18:59:59.543Z Has data issue: false hasContentIssue false
  • English
  • Français

Facilitating Access to a COVID-19 Vaccine through Global Health Law

Published online by Cambridge University Press:  01 January 2021

Lawrence O. Gostin ,
Safura Abdool Karim  and
Benjamin Mason Meier
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns: Global Health Law
Information
Journal of Law, Medicine & Ethics , Volume 48 , Issue 3: A Bold Agenda for the Next Steps in Health Reform , Fall 2020 , pp. 622 - 626
Copyright
Copyright © American Society of Law, Medicine and Ethics 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Graham, B.S., “Rapid COVID-19 Vaccine Development” Rapid COVID-19 Vaccine Development 368, no. 6494 (2020): 945–946.Google ScholarPubMed
Moon, S. et al., “Global Public Goods For Health: Weaknesses and Opportunities in the Global Health System,” Global Public Goods For Health: Weaknesses and Opportunities in the Global Health System, 12, no. 2 (2017): 195–205.Google Scholar
Cueto, M. et al., The World Health Organization: A History (Cambridge University Press, 2019).CrossRefGoogle Scholar
G. Makenga et al., “Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable Vaccine Introduction,” Frontiers in Public Health (2019), available at <https://www.frontiersin.org/articles/10.3389/fpubh.2019.00056/full> (last visited August 19, 2020).+(last+visited+August+19,+2020).>Google Scholar
Usher, A., “COVID-19 Vaccines For All?” COVID-19 Vaccines For All? 395, no. 10240 (2020): 1822–1823.Google ScholarPubMed
Bollyky, T.M., Gostin, L.O., and Hamburg, M.A., “The Equitable Distribution of COVID-19 Therapeutics and Vaccines,” JAMA 323, no. 24 (2020): 2462–2463, doi:10.1001/jama.2020.6641.CrossRefGoogle ScholarPubMed
L. Gostin, O. and Meier, B.M., Foundations of Global Health & Human Rights (Cambridge University Press, 2020).CrossRefGoogle Scholar
Ball, P., “Anti-Vaccine Movement Could Undermine Efforts to End Coronavirus Pandemic, Researchers Warn,” Nature 581 (2020): 251, available at <https://www.nature.com/articles/d41586-020-01423-4> (last visited August 19, 2020).CrossRefGoogle ScholarPubMed
United Nations, Committee on Economic, Social and Cultural Rights, Substantive issues arising in the implementation of the International Covenant on Economic, Social and Cultural Rights: General Comment No. 14, Geneva: United Nations; 2000, U.N. Doc. E/C.12/2000/4.Google Scholar
United Nations. Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. Promotion and protection of human rights: human rights questions, including alternative approaches for improving the effective enjoyment of human rights and fundamental freedoms; Sept. 13, 2006, UN Doc. A/61/338.Google Scholar
United Nations,, Committee on Economic, Social and Cultural Rights, General comment No. 25 (2020) on science and economic, social and cultural rights (article 15 (1) (b), (2), (3) and (4) of the International Covenant on Economic, Social and Cultural Rights), Geneva: United Nations; 2020, U.N. Doc. E/C.12/GC/25.Google Scholar
B. Meier, M., A.e Gelpi, M.Kavanagh, M., Forman, L., and Amon, J.J., “Employing Human Rights Frameworks to Realize Access to an HIV Cure,” Employing Human Rights Frameworks to Realize Access to an HIV Cure, 18, no. 1 (2015): 1–7.Google Scholar
United Nations, supra note 9, para. 31.Google Scholar
Id., para. 12.Google Scholar
Usher, A., “COVID-19 Vaccines For All?” COVID-19 Vaccines For All? 395, no. 10240 (2020): 1822–1823, available at <https://doi.org/10.1016/S0140-6736(20)31354-4> (last visited August 19, 2020).Google ScholarPubMed
Capretta, J.C., “The Fragile Vaccine Plan to Save the World: The Fast-Moving Partnership Between Governments and Philanthropy Merits U.S. Backing,” The Bulwark, July 29, 2020, available at <https://thebulwark.com/the-fragile-vaccine-plan-to-save-the-world/> (last visited August 19, 2020).+(last+visited+August+19,+2020).>Google Scholar
World Health Organization, Pandemic Influenza Preparedness (Framework, PIP., available at <https://www.who.int/influenza/pip/en/> (last visited August 19, 2020).+(last+visited+August+19,+2020).>Google Scholar
“Global Governance for COVID-19 Vaccines,” The Lancet 395 (2020): 1883.CrossRefGoogle Scholar
Petchesky, R.P., Global Prescriptions: Gendering Health and Human Rights (Zed Books, 2006).Google Scholar
Huddart, S., Nash, M., Abdelrasoul, A., Bacearnicova, I., Bourque, K., and Mishra, L., “The Doha Declaration in Action: An Examination of Patent Law Flexibilities in the South African Acquired Immunodeficiency Syndrome Epidemic,” Journal of Health Specialties 5 (2017): 30–34; M.Islam, D., W.Kaplan, A., Trachtenberg, D., et al., “Impacts of Intellectual Property Provisions in Trade Treaties on Access to Medicine in Low and Middle Income Countries: A Systematic Review,” Global Health 15, no. 1 (2019): 88-102.CrossRefGoogle Scholar
WHO Regional Office for South-East Asia, 23rd Meeting of Health Ministers of Countries of SEAR, “Access to Medicines and Vaccines: Implications of Intellectual Property Protection and Trade Agreements” SEA/HMM/ Meet23/5 (August 18, 2005).Google Scholar
“The Medicines Patent Pool,” Unitaid, July 29, 2019), available at <https://unitaid.org/project/medicines-patentpool> (last visited August 19, 2020).+(last+visited+August+19,+2020).>Google Scholar
Perehudoff, K. and Sellin, K., “COVID- 19 Technology Access Pool (C-TAP): A Promising Human Rights Approach,” Health and Human Rights Blog, available at <https://www.hhrjournal.org/2020/06/covid-19-technology-accesspool-c-tap-a-promising-human-rightsapproach/> (last visited August 19, 2020).+(last+visited+August+19,+2020).>Google Scholar
World Health Organisation, “COVID- 19 technology access pool,” available at <https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/covid-19-technology-accesspool> (last visited August 19, 2020).+(last+visited+August+19,+2020).>Google Scholar
Moran, M., et al., “Registering New Drugs for Low-Income Countries: The African Challenge,” PLoS Medicine 8, no. 2 (2011): e1000411.CrossRefGoogle ScholarPubMed
Ghedamu, T.B. and Meier, B.M., “Assessing National Public Health Law to Prevent Infectious Disease Outbreaks: Immunization Law as a Basis for Global Health Security,” Assessing National Public Health Law to Prevent Infectious Disease Outbreaks: Immunization Law as a Basis for Global Health Security, 47, no. 3 (2019): 412–426.Google Scholar
Dellepiane, N. and Wood, D., “Twenty- Five Years of the WHO Vaccines Prequalification Programme (1987– 2012): Lessons Learned and Future Perspectives,” Twenty- Five Years of the WHO Vaccines Prequalification Programme (1987– 2012): Lessons Learned and Future Perspectives, 33, no. 1 (2015): 52–61.Google Scholar
World Health Organisation, “Prequalification,” available at <https://www.who.int/rhem/prequalification/en/> (last visited August 19, 2020).+(last+visited+August+19,+2020).>Google Scholar
Duclos, P., “National Immunization Technical Advisory Groups (NITAGs): Guidance for Their Establishment and Strengthening,” Vaccine 28, Suppl. 1 (2010): A18-25.CrossRefGoogle ScholarPubMed